Instituto De Cancerología De Sucre
Instituto de Cancerología de Sucre (Incans) is a private Colombian oncology institution founded in 2000 in Sincelejo, delivering comprehensive cancer care — diagnostics, chemotherapy, radiotherapy, and multiple surgical specialties — to patients across Sucre department via Colombia's SGSSS health system.
- Company typePrivate
- Founded2000
- HeadquartersSincelejo, Colombia
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Instituto De Cancerología De Sucre does
Instituto de Cancerología de Sucre S.A.S. ("Incans") is a private oncology institution founded in 2000 in Sincelejo, Sucre, Colombia, operating as a regional referral center for cancer care at the departmental level. The institution delivers a vertically integrated oncology platform that spans the full continuum of cancer diagnosis and treatment, including six clinical specialties (clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology and soft tissue, orthopedic oncology) and ancillary service lines covering chemotherapy, radiotherapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratories, hospitalization, pharmacy and compounding, and pre-transfusion management. Headcount is small (~20 employees) and the technology stack is described generically as "state-of-the-art" without disclosed platforms or proprietary systems, though a digital patient portal is hosted via a third-party telemedicine partner (Gotelemedicina).
The revenue model is professional-services based: Incans bills for consultations and procedures delivered on-site at its Cra. 22 #14-18 facility, with payment sourced from patients affiliated with Colombia's mandatory health insurance system (SGSSS) — specifically via Empresas Promotoras de Salud (EPS) and Instituciones Prestadoras de Servicios (IPS) — as well as direct private-pay patients. Go-to-market is sales-led and referral-driven rather than consumer-marketing-led, leveraging institutional affiliations with allied healthcare entities rather than direct acquisition. The institution maintains an informational and community-education presence across Facebook, Instagram, X, YouTube, and TikTok, and uses its website (incans.com.co) for service information and appointment scheduling. Pricing is not publicly disclosed and contracts under the Colombian system are administered through EPS/IPS arrangements.
Incans has no disclosed funding history, no parent company, no subsidiaries, and no executive team information in the public record. Ownership is private under Colombia's S.A.S. corporate form with no external investors identified. Over more than 20 years of continuous operation, the institution has progressively expanded its service network to consolidate its position as the primary oncology referral center in the Sucre department, addressing a structural gap in specialized cancer care access outside of Colombia's major metropolitan areas.
Instituto De Cancerología De Sucre firmographics
Firmographics- Name
- Instituto De Cancerología De Sucre
- Legal name
- Instituto de Cancerología de Sucre S.A.S.
- Website
- https://incans.com.co
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Instituto de Cancerología de Sucre (Incans) is a private Colombian oncology institution founded in 2000 in Sincelejo, delivering comprehensive cancer care — diagnostics, chemotherapy, radiotherapy, and multiple surgical specialties — to patients across Sucre department via Colombia's SGSSS health system.
- Ownership category
- akta.pro rank
Instituto De Cancerología De Sucre industry classification
Industry- Product category
- Oncology Healthcare Services
- NAICS
- Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Genitourinary Oncology (HLAKAFAM), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where Instituto De Cancerología De Sucre is headquartered
LocationHeadquarters
- HQ city
- Sincelejo
- HQ country
- Colombia
- HQ region
- Latin America
Offices1 record
Markets served
Instituto De Cancerología De Sucre business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Services Revenue: Revenue generated from specialized oncology consultations, chemotherapy, radiotherapy, nuclear medicine, diagnostic imaging, clinical laboratory, pathology laboratory, hospitalization, and surgical procedures. Services are provided to patients covered by insurance (EPS), government health plans, and private pay patients.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Instituto De Cancerología De Sucre product offering
Product offeringCore offering
Instituto De Cancerología De Sucre (Incans) is a private oncology healthcare institution founded in 2000 in Sincelejo, Sucre, Colombia. It provides comprehensive specialized oncology care including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratory, hospitalization, pharmacy, and pre-transfusion management services. The institution serves as a regional referral center for cancer treatment within the Sucre department.
Product overview
Instituto de Cancerología de Sucre S.A.S. is a private oncology institute established in 2000, offering a comprehensive cancer care ecosystem. The institution operates as a unified platform of specialized medical services including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical laboratory, pathology laboratory, hospitalization, pharmacy, and pre-transfusion management. All services are delivered through state-of-the-art technology and a highly specialized medical team, serving as a regional referral center in Sucre, Colombia.
Differentiator
Problem solved
Functional benefit
Products and services
- Oncología clínica (Clinical Oncology)
Companies that use Instituto De Cancerología De Sucre
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Instituto De Cancerología De Sucre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Instituto De Cancerología De Sucre partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Instituto De Cancerología De Sucre competitors and assessment
Company assessmentDirect peers
- Fundación Santa Fe de Bogotá: Leading private hospital in Bogotá with an established oncology center. Comparable as a high-acuity Colombian provider offering multi-specialty oncology services including advanced diagnostics and treatment.
- Clínica Universidad de La Sabana: University-affiliated clinic near Bogotá offering oncology services. Comparable as a private Colombian provider of specialized cancer care, with academic/clinical research affiliation.
- Instituto Nacional de Cancerología: Colombia's national public cancer institute headquartered in Bogotá. Directly comparable as a specialized oncology center offering diagnosis, treatment, and research services, though operating at national scale and as a public reference center.
- Clínica del Country: Bogotá-based private clinic with a recognized oncology unit. Comparable as a Colombian private institution delivering specialized cancer diagnosis and treatment.
- Hospital Pablo Tobón Uribe: High-complexity private hospital in Medellín with oncology services. Comparable as a Colombian tertiary provider offering integrated cancer care, though at larger scale and located in a major city.
- Centro Médico Imbanaco: Major private hospital in Cali with a comprehensive oncology program. Comparable as a Colombian private provider offering integrated cancer care including chemo, radiotherapy, and surgical oncology.
- Centro de Tratamiento e Investigación sobre Cáncer (CTIC) Luis Carlos Sarmiento Angulo: Cancer treatment and research center in Bogotá offering comprehensive oncology services. Comparable as a dedicated cancer treatment center with similar scope of chemotherapy, radiotherapy, and diagnostics.
Broad incumbents
- Hospital Universitario San Ignacio: Major academic hospital in Bogotá with oncology services. Comparable as a comprehensive Colombian provider including cancer care, but with broader service portfolio beyond oncology.
- MD Anderson Cancer Center: Global leader in oncology care and research. Comparable as an oncology-focused institution, though operating at vastly larger scale and representing the upper benchmark of cancer center capabilities.
Regional players
- Centro Hospitalario Serena del Mar: Modern hospital in Cartagena serving the Caribbean coast region. Comparable oncology offerings, but competes with Incans' catchment area for Caribbean-coast referrals from Sucre.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Instituto De Cancerología De Sucre social profiles
Digital presenceInstituto De Cancerología De Sucre financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto De Cancerología De Sucre leadership team
Management profileNumber of profiles
Instituto De Cancerología De Sucre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto De Cancerología De Sucre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto De Cancerología De Sucre
What does Instituto De Cancerología De Sucre do?
Instituto De Cancerología De Sucre (Incans) is a private oncology healthcare institution founded in 2000 in Sincelejo, Sucre, Colombia. It provides comprehensive specialized oncology care including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratory, hospitalization, pharmacy, and pre-transfusion management services. The institution serves as a regional referral center for cancer treatment within the Sucre department.
Is Instituto De Cancerología De Sucre a public or private company?
Instituto De Cancerología De Sucre is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Instituto De Cancerología De Sucre founded?
Instituto De Cancerología De Sucre was founded in 2000. It employs 11 to 50 people.
Where is Instituto De Cancerología De Sucre based?
Instituto De Cancerología De Sucre is headquartered in Sincelejo, Colombia, in the Latin America region.
How does Instituto De Cancerología De Sucre make money?
One revenue line is on record: medical Services Revenue.
Who are Instituto De Cancerología De Sucre's main competitors?
Direct peers on record are Fundación Santa Fe de Bogotá, Clínica Universidad de La Sabana, Instituto Nacional de Cancerología, Clínica del Country, Hospital Pablo Tobón Uribe, Centro Médico Imbanaco and Centro de Tratamiento e Investigación sobre Cáncer (CTIC) Luis Carlos Sarmiento Angulo. Broad incumbents are Hospital Universitario San Ignacio and MD Anderson Cancer Center. Centro Hospitalario Serena del Mar is listed as a regional player.
Does Instituto De Cancerología De Sucre have an API?
No public API is recorded for Instituto De Cancerología De Sucre.
What industry is Instituto De Cancerología De Sucre in?
Instituto De Cancerología De Sucre's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAM, Genitourinary Oncology. Its NAICS code is 621 and its SIC code is 8093.